Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'paroxetine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 969 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Deahl, M
      Pharmacological treatment of depression: the role of paroxetine

      HOSPITAL MEDICINE
    2. Rosenberg, DR; MacMillan, SN; Moore, GJ
      Brain anatomy and chemistry may predict treatment response in paediatric obsessive-compulsive disorder

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    3. Tournel, G; Houdret, N; Hedouin, V; Deveaux, M; Gosset, D; Lhermitte, M
      High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum

      JOURNAL OF CHROMATOGRAPHY B
    4. Macek, J; Ptacek, P; Klima, J
      Rapid determination of citalopram in human plasma by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    5. Frolich, J; Wiater, A; Lehmkuhl, G
      Successful treatment of severe parasomnias with paroxetine in a 12-year-old boy

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    6. Rouillon, F
      Depression comorbid with anxiety or medical illness: The role of paroxetine

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    7. Courtet, P; Baud, P; Abbar, M; Boulenger, JP; Castelnau, D; Mouthon, D; Malafosse, A; Buresi, C
      Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene

      MOLECULAR PSYCHIATRY
    8. Mossner, R; Henneberg, A; Schmitt, A; Syagailo, YV; Grassle, M; Hennig, T; Simantov, R; Gerlach, M; Riederer, P; Lesch, KP
      Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease

      MOLECULAR PSYCHIATRY
    9. Govoni, S; Racchi, M; Masoero, E; Zamboni, M; Ferini-Strambi, L
      Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly

      MOLECULAR PSYCHIATRY
    10. Brooks, DJ; Doder, M
      Depression in Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    11. Shen, H; Numachi, Y; Yoshida, S; Toda, S; Awata, S; Matsuoka, H; Sato, M
      Electroconvulsive shock regulates serotonin transporter mRNA expression inrat raphe nucleus

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    12. Arnold, LM; Auchenbach, MB; McElroy, SL
      Psychogenic excoriation - Clinical features, proposed diagnostic criteria,epidemiology and approaches to treatment

      CNS DRUGS
    13. Fritze, J; Moller, HJ
      Design of clinical trials of antidepressants - Should a placebo control arm be included?

      CNS DRUGS
    14. Hensley, PL; Nurnberg, HG
      Formulary restriction of selective serotonin reuptake inhibitors for depression - Potential pitfalls

      PHARMACOECONOMICS
    15. Sanchez-Lacay, JA; Lewis-Fernandez, R; Goetz, D; Blanco, C; Salman, E; Davies, S; Liebowitz, M
      Open trial of nefazodone among Hispanics with major depression: Efficacy, tolerability, and adherence issues

      DEPRESSION AND ANXIETY
    16. Bump, GM; Mulsant, BH; Pollock, BG; Mazumdar, S; Begley, AE; Dew, MA; Reynolds, CF
      Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly

      DEPRESSION AND ANXIETY
    17. Armstrong, EP; Abarca, J
      An examination of the relationship between non-depression-related costs and uninterrupted Tx

      FORMULARY
    18. Leis, HJ; Windischhofer, W; Raspotnig, G; Fauler, G
      Stable isotope dilution negative ion chemical ionization gas chromatography-mass spectrometry for the quantitative analysis of paroxetine in human plasma

      JOURNAL OF MASS SPECTROMETRY
    19. Nahshoni, E; Aizenberg, D; Sigler, M; Zalsman, G; Strasberg, B; Imbar, S; Weizman, A
      Heart rate variability in elderly patients before and after electroconvulsive therapy

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    20. Lobbezoo, F; van Denderen, RJA; Verheij, JGC; Naeije, M
      Reports of SSRI-associated bruxism in the family physician's office

      JOURNAL OF OROFACIAL PAIN
    21. Oosterbaan, DB; van Balkom, AJLM; Spinhoven, P; van Oppen, P; van Dyck, R
      Cognitive therapy versus moclobemide in social phobia: A controlled study

      CLINICAL PSYCHOLOGY & PSYCHOTHERAPY
    22. McDaniel, WW
      Serotonin syndrome: Early management with cyproheptadine

      ANNALS OF PHARMACOTHERAPY
    23. Bostic, JQ; Prince, J; Brown, K; Place, S
      A retrospective study of citalopram in adolescents with depression

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    24. Pace-Schott, EF; Gersh, T; Silvestri, R; Stickgold, R; Salzman, C; Hobson, JA
      SSRI Treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects

      JOURNAL OF SLEEP RESEARCH
    25. Siegle, I; Fritz, P; Eckhardt, K; Zanger, UM; Eichelbaum, M
      Cellular localization and regional distribution of CYP2D6 mRNA and proteinexpression in human brain

      PHARMACOGENETICS
    26. Liu, LT; Hong, PC; Huang, HL; Chen, SF; Wang, CLJ; Wen, YS
      Asymmetric syntheses of trans-3,4-disubstituted 2-piperidinones and piperidines

      TETRAHEDRON-ASYMMETRY
    27. Mehlum, L
      Suicidal behaviour and personality disorder

      CURRENT OPINION IN PSYCHIATRY
    28. Navratilova, H
      Use of S-Mosher acid as a chiral solvating agent for enantiomeric analysisof some trans-4-(4-fluorophenyl)-3-substituted-1-methylpiperidines by means of NMR spectroscopy

      CHIRALITY
    29. Dulchin, MC; Oquendo, MA; Malone, KM; Ellis, SP; Li, SH; Mann, JJ
      Prolactin response to dl-fenfluramine challenge before and after treatmentwith paroxetine

      NEUROPSYCHOPHARMACOLOGY
    30. Moreau, X; Jeanningros, R; Mazzola-Pomietto, P
      Chronic effects of triiodothyronine in combination with imipramine on 5-HTtransporter, 5-HT1A and 5-HT2A receptors in adult rat brain

      NEUROPSYCHOPHARMACOLOGY
    31. Mann, JJ; Brent, DA; Arango, V
      The neurobiology and genetics of suicide and attempted suicide: A focus onthe serotonergic system

      NEUROPSYCHOPHARMACOLOGY
    32. Fairbanks, LA; Melega, WP; Jorgensen, MJ; Kaplan, JR; McGuire, MT
      Social impulsivity inversely associated with CSF5-HIAA and fluoxetine exposure in vervet monkeys

      NEUROPSYCHOPHARMACOLOGY
    33. Weintraub, D
      Nortriptyline in geriatric depression resistant to serotonin reuptake inhibitors: Case series

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    34. Keller, MB; Ryan, ND; Strober, M; Klein, RG; Kutcher, SP; Birmaher, B; Hagino, OR; Koplewicz, H; Carlson, GA; Clarke, GN; Emslie, GJ; Feinberg, D; Geller, B; Kusumakar, V; Papatheodorou, G; Sack, WH; Sweeney, M; Wagner, DK; Weller, EB; Winters, NC; Oakes, R; McCafferty, JP
      Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    35. Busatto, GF; Buchpiguel, CA; Zamignani, DR; Garrido, GEJ; Glabus, MF; Rosario-Campos, MC; Castro, CC; Maia, A; Rocha, ET; McGuire, PK; Miguel, EC
      Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: An exploratory SPECT study

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    36. Staley, JK; Krishnan-Sarin, S; Zoghbi, S; Tamagnan, G; Fujita, M; Seibyl, JP; Maciejewski, PK; O'Malley, S; Innis, RB
      Sex differences in [I-123]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

      SYNAPSE
    37. Navarro, HA; Xu, H; Zhong, D; Blough, BE; Ross, WP; Kuhar, MJ; Carroll, FI
      [(125) I]3 beta-(4-ethyl-3-iodophenyl)nortropane-2 beta-carboxylic acid methyl ester ([I-125]EINT): A potent and selective radioligand for the brain serotonin transporter

      SYNAPSE
    38. Cumming, P; Kretzschmar, M; Brust, P; Smith, DF
      Quantitative radioluminography of serotonin uptake sites in the porcine brain

      SYNAPSE
    39. Dugar, A; Keck, BJ; Maines, LW; Miller, S; Njai, R; Lakoski, JM
      Compensatory responses in the aging hippocampal serotonergic system following neurodegenerative injury with 5,7-dihydroxytryptamine

      SYNAPSE
    40. Ruwe, FJL; Smulders, RA; Kleijn, HJ; Hartmans, HLA; Sitsen, JMA
      Mirtazapine and paroxetine: a drug-drug interaction study in healthy subjects

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    41. Lepine, JP; Altamura, C; Ansseau, M; Gutierrez, JLA; Bitter, I; Lader, M; Waintraub, L
      Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    42. Biswas, AB; Bhaumik, S; Branford, D
      Treatment-emergent behavioural side effects with selective serotonin re-uptake inhibitors in adults with learning disabilities

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    43. Kennedy, SH; Eisfeld, BS; Meyer, JH; Bagby, RM
      Antidepressants in clinical practice: Limitations of assessment methods and drug response

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    44. Gardier, AM; Trillat, AC; Malagie, I; David, D; Hascoet, M; Coombel, MC; Jolliet, P; Jacquot, C; Hen, R; Bourin, M
      5-MT1B receptors mediate the antidepressant effects of selective serotoninreuptake inhibitors.

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    45. Navratilova, H
      Enantiomeric analysis of (3S,4R)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine by F-19 NMR spectroscopy

      MAGNETIC RESONANCE IN CHEMISTRY
    46. Rivas-Vazquez, RA
      Antidepressants as first-line agents in the current pharmacotherapy of anxiety disorders

      PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE
    47. Dell'Agnello, G; Ceravolo, R; Nuti, A; Bellini, G; Piccinni, A; D'Avino, C; Dell'Osso, L; Bonuccelli, U
      SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study

      CLINICAL NEUROPHARMACOLOGY
    48. Kuikka, JT; Tammela, L; Bergstrom, KA; Karhunen, L; Uusitupa, M; Tiihonen, J
      Effects of ageing on serotonin transporters in healthy females

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    49. Pacher, P; Ungvari, Z
      Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels

      MEDICAL HYPOTHESES
    50. Meier, CR; Schlienger, RG; Jick, H
      Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    51. Bixo, M; Allard, P; Backstrom, T; Mjorndal, T; Nyberg, S; Spigset, O; Sundstrom-Poromaa, I
      Binding of [H-3]paroxetine to serotonin uptake sites and of [H-3]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment

      PSYCHONEUROENDOCRINOLOGY
    52. Scarr, E; Copolov, DL; Dean, B
      A proposed pathological model in the hippocampus of subjects with schizophrenia

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    53. Mauri, MC; Boscati, L; Volonteri, LS; Scalvini, ME; Steinhilber, CPC; Laini, V; Zamberlan, F
      Predictive value of amino acids in the treatment of major depression with fluvoxamine

      NEUROPSYCHOBIOLOGY
    54. Marazziti, D; Baroni, S; Rossi, A; Masala, I; Giannaccini, G; Gori, V; Lucacchini, A; Cassano, GB
      Pharmacological characterization of the serotonin transporter in young andelderly subjects

      NEUROPSYCHOBIOLOGY
    55. Marazziti, D; Conti, L; Pfanner, C; Presta, S; Rossi, A; Gemignani, A; Dell'Osso, L; Cassano, GB
      No correlation between aggression and platelet H-3-paroxetine binding in obsessive-compulsive disorder patients

      NEUROPSYCHOBIOLOGY
    56. Konig, F; von Hippel, C; Petersdorff, T; Neuhoffer-Weiss, M; Wolfersdorf, M; Kaschka, WP
      First experiences in combination therapy using olanzapine with SSRIs (Citalopram, paroxetine) in delusional depression

      NEUROPSYCHOBIOLOGY
    57. Oosterbaan, DB; Van Balkom, AJLM; Van Boeijen, CA; De Meij, TGJ; Van Dyck, R
      An open study of paroxetine in hypochondriasis

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    58. O'Loinsigh, ED; Boland, G; Kelly, JP; O'Boyle, KM
      Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    59. Krishnan, KRR; Doraiswamy, PM; Clary, CM
      Clinical and treatment response characteristics of late-life depression associated with vascular disease: A pooled analysis of two multicenter trialswith sertraline

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    60. Ginovart, N; Wilson, AA; Meyer, JH; Hussey, D; Houle, S
      Positron emission tomography quantification of [C-11]-DASB binding to the human serotonin transporter: Modeling strategies

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    61. Meyer, JM
      Individual changes in clozapine levels after smoking cessation: Results and a predictive model

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    62. Rausch, JL; Mac Hobby, H; Shendarkar, N; Johnson, RE; Li, JQ
      Fluvoxamine treatment of mixed anxiety and depression: Evidence for serotonergically mediated anxiolysis

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    63. Ekselius, L; von Knorring, L
      Effect on sexual function of kong-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    64. Harvey, AT; Preskorn, SH
      Fluoxetine pharmacokinetics and effect on CYP2C19 in young and elderly volunteers

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    65. Labbate, LA; Brodrick, PS; Nelson, RP; Lydiard, RB; Arana, GW
      Effects of bupropion sustained-release on sexual functioning and nocturnalerections in healthy men

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    66. Baldwin, DS; Hawley, CJ; Mellors, K
      A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment

      JOURNAL OF PSYCHOPHARMACOLOGY
    67. Schmitt, JAJ; Kruizinga, MJ; Riedel, WJ
      Non-serotonergic pharmacological profiles and associated cognitive effectsof serotonin reuptake inhibitors

      JOURNAL OF PSYCHOPHARMACOLOGY
    68. Osterbaan, DB; van Balkom, AJLM; Spinhoven, P; van Dyck, R
      The placebo response in social phobia

      JOURNAL OF PSYCHOPHARMACOLOGY
    69. Melichar, JK; Haida, A; Rhodes, C; Reynolds, AH; Nutt, DJ; Malizia, AL
      Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers

      JOURNAL OF PSYCHOPHARMACOLOGY
    70. Montgomery, SA
      A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    71. Stain-Malmgren, R; El Khoury, A; Aberg-Wistedt, A; Tham, A
      Serotonergic function in major depression and effect of sertraline and paroxetine treatment

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    72. Martinez, J; Perez, S; Oficialdegui, AM; Heras, B; Orus, L; Villanueva, H; Palop, JA; Roca, J; Mourelle, M; Bosch, A; Del Castillo, JC; Lasheras, B; Tordera, R; del Rio, J; Monge, A
      New 3-[4-(aryl)piperazin-1-yl]-1(benzo[b]thiophen3-yl) propane derivativeswith dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    73. Hebert, C; Habimana, A; Elie, R; Reader, TA
      Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study

      NEUROCHEMISTRY INTERNATIONAL
    74. Laux, G
      Cost-benefit analysis of newer versus older antidepressants - Pharmacoeconomic studies comparing SSRIs/SNRIs with tricyclic antidepressants

      PHARMACOPSYCHIATRY
    75. Fartoux-Heymann, L; Hezode, C; Zafrani, ES; Dhumeaux, D; Mallat, A
      Acute fatal hepatitis related to sertraline

      JOURNAL OF HEPATOLOGY
    76. Pezzella, G; Moslinger-Gehmayr, R; Contu, A
      Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline

      BREAST CANCER RESEARCH AND TREATMENT
    77. Raines, KW; Seidler, FJ; Slotkin, TA
      Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos

      DEVELOPMENTAL BRAIN RESEARCH
    78. Marazziti, D; Dell'Osso, L; Rossi, A; Masala, I; Baroni, S; Armani, A; Giannaccini, G; Di Nasso, E; Lucacchini, A; Cassano, GB
      Decreased platelet [H-3]paroxetine binding sites in suicide attempters

      PSYCHIATRY RESEARCH
    79. Nebes, RD; Butters, MA; Houck, PR; Zmuda, MD; Aizenstein, H; Pollock, BG; Mulsant, BH; Reynolds, CF
      Dual-task performance in depressed geriatric patients

      PSYCHIATRY RESEARCH
    80. Agelink, MW; Majewski, T; Wurthmann, C; Postert, T; Linka, T; Rotterdam, S; Klieser, E
      Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone

      JOURNAL OF AFFECTIVE DISORDERS
    81. de la Torre, BR; Dreher, J; Malevany, L; Bagli, M; Kolbinger, M; Omran, H; Luderitz, B; Rao, ML
      Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

      THERAPEUTIC DRUG MONITORING
    82. Spina, E; Avenoso, A; Facciola, G; Scordo, MG; Ancione, M; Madia, A
      Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine

      THERAPEUTIC DRUG MONITORING
    83. Walker, JB; Klein, RM; Yee, SL
      Type II error and antidepressants

      JOURNAL OF CLINICAL PSYCHIATRY
    84. Weihs, KL; Batey, SR; Houser, TL; Donahue, RMJ; Ascher, JA
      Type II error and antidepressants - Dr. Weihs and colleagues reply

      JOURNAL OF CLINICAL PSYCHIATRY
    85. Zisook, S; Shuchter, SR; Pedrelli, P; Sable, J; Deaciuc, SC
      Bupropion sustained release for bereavement: Results of an open trial

      JOURNAL OF CLINICAL PSYCHIATRY
    86. Sussman, N; Ginsberg, DL; Bikoff, J
      Effects of nefazodone on body weight: A pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials

      JOURNAL OF CLINICAL PSYCHIATRY
    87. Clayton, AH; McGarvey, EL; Abouesh, AI; Pinkerton, RC
      Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction

      JOURNAL OF CLINICAL PSYCHIATRY
    88. Montejo, AL; Llorca, G; Izquierdo, JA; Rico-Villademoros, F
      Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients

      JOURNAL OF CLINICAL PSYCHIATRY
    89. Nelson, JC
      Diagnosing and treating depression in the elderly

      JOURNAL OF CLINICAL PSYCHIATRY
    90. Blier, P
      Pharmacology of rapid-onset antidepressant treatment strategies

      JOURNAL OF CLINICAL PSYCHIATRY
    91. Nierenberg, AA
      Do some antidepressants work faster than others?

      JOURNAL OF CLINICAL PSYCHIATRY
    92. Pollack, MH
      Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    93. Schneier, FR
      Treatment of social phobia with antidepressants

      JOURNAL OF CLINICAL PSYCHIATRY
    94. Coleman, CC; King, BR; Bolden-Watson, C; Book, MJ; Segraves, RT; Richard, N; Ascher, J; Batey, S; Jamerson, B; Metz, A
      A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

      CLINICAL THERAPEUTICS
    95. Dewa, CS; Hoch, JS; Goering, P
      Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures

      CLINICAL THERAPEUTICS
    96. Dams, R; Benijts, THP; Lambert, WE; Van Bocxlaer, JF; Van Varenbergh, D; Peteghem, CV; De Leenheer, AP
      A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication

      JOURNAL OF ANALYTICAL TOXICOLOGY
    97. Whyte, IM; Isbister, GK
      Misdiagnosis of myoclonus in antidepressant induced serotonin excess

      VETERINARY AND HUMAN TOXICOLOGY
    98. Kranzler, HR; Van Kirk, J
      Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    99. Haddad, PM
      Antidepressant discontinuation syndromes - Clinical relevance, prevention and management

      DRUG SAFETY
    100. Barret, JE; Williams, JW; Oxman, TE; Frank, E; Katon, W; Sullivan, M; Hegel, MT; Cornell, JE; Sengupta, AS
      Treatment of dysthymia and minor depression in primary care - A randomizedtrial in patients aged 18 to 59 years

      JOURNAL OF FAMILY PRACTICE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/02/20 alle ore 09:14:59